The Prevalence and Risk Factors of Acute Myocardial Infarction (AMI) After Acute Ischemic Stroke (AIS) in the United States

Authors

Ali Seifi, MD, Thomas Jefferson UniversityFollow
Fred Rincon, MD, MSc, Thomas Jefferson UniversityFollow
Michael Moussouttas, MD, Thomas Jefferson UniversityFollow
Mitchell Maltenfort, PhD, Thomas Jefferson UniversityFollow
Matthew Vibbert, MD, Thomas Jefferson UniversityFollow
Rodney Bell, MD, Thomas Jefferson UniversityFollow
Maria Carissa Pineda, MD, Thomas Jefferson UniversityFollow
Diana Tzeng, MD, Thomas Jefferson UniversityFollow
Jacqueline Urtecho, MD, Thomas Jefferson UniversityFollow
Anish Koka, MD, Thomas Jefferson UniversityFollow
William McBride, MD, Thomas Jefferson UniversityFollow

Document Type

Poster

Publication Date

11-2011

Abstract

Objectives: To determine the prevalence and risk factors for, and the association with in-hospital mortality of, AMI after AIS, and to study the effect of intravenous recombinant tissue plasminogen activator (r-tPA) in this setting. We hypothesized that AMI would be associated with lower survival rate at hospital discharge but that intravenous r-tPA would be associated with lower risk of AMI.

Recommended Citation

Seifi, MD, Ali; Rincon, MD, MSc, Fred; Moussouttas, MD, Michael; Maltenfort, PhD, Mitchell; Vibbert, MD, Matthew; Bell, MD, Rodney; Pineda, MD, Maria Carissa; Tzeng, MD, Diana; Urtecho, MD, Jacqueline; Koka, MD, Anish; and McBride, MD, William, "The Prevalence and Risk Factors of Acute Myocardial Infarction (AMI) After Acute Ischemic Stroke (AIS) in the United States" (2011). Department of Neurology Faculty Papers. Paper 41.
https://jdc.jefferson.edu/neurologyfp/41